News | News By Subject | News by Disease News By Date | Search News

Herpes genital (genital Herpes simplex) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial     8/28/2017
Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes     3/10/2017
Genocea (GNCA) Stock Doubles After Market Yesterday on Positive 12 Months Genital Herpes Data     4/1/2016
Genocea Biosciences (GNCA)'s GEN-003 Meets Primary Endpoint In Phase II Genital Herpes Trial     10/7/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
Vical  (VICL) Herpes Vaccine Clinical Trial Disappoints with "Confounding Results"     6/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
GlaxoSmithKline (GSK)'s Herpes Vaccine Fails in Trial, US National Institutes of Health (NIH) Says     9/30/2010
BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad(R)     8/26/2009
Starpharma Holdings Ltd Reports Positive VivaGel(R) Clinical Study Results     5/12/2008
Sciele Pharma, Inc. (SCRX) Signs Exclusive Zovirax(R) Promotional Agreement With Biovail Corporation (BVF)     12/20/2006
Renovis, Inc. (RNVS) Drug Fails Mid-Stage Trial     3/8/2005
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights     3/4/2005

News from Around the Web
Thiel-Backed Biotech Rational Vaccines Will Follow FDA Guidelines After Offshore Trial Controversy     9/5/2017
Constipated? Study Finds Surprising Cause, Yale University Reveals     6/9/2016
Experimental Vaccine Cures Pre-Cancer Vulvar Growths, Leiden University Medical Center Study     11/5/2009
Herpes Medication Does Not Reduce Risk Of HIV Transmission, University of Washington Study     5/8/2009
Cream 'Could Stop Genital Herpes', Harvard Medical School Study     1/22/2009
Herpes Virus Changes Anti-Herpes Drug to Form that Hinders AIDS Virus, National Institutes of Health (NIH) Study     9/11/2008
Second Study Finds Treating Herpes Won't Stop HIV, London School of Hygiene and Tropical Medicine Study     3/13/2008
Novel Vaccine Concept Developed By Scientists At The Wistar Institute     1/31/2008
Drugs Can Lower Risk of Genital Herpes Recurrence     8/14/2007
New Approach Offers Hope For An Effective Herpes Vaccine     1/22/2007
Study Shows How Herpes Infects Cornea, Evades immune cells     9/25/2006
New Study Shows Herpes Cases Declining     8/23/2006
Experimental Vaginal Gel Inhibits HIV And HSV     1/24/2006
FDA Proposes Easing Rules On Herpes Tests     1/9/2006
One-Day Antiviral Treats Recurrent Genital Herpes     1/3/2006

Press Releases
Genocea (GNCA) Reports Positive Top-Line 12-Month Phase IIb Data For GEN-003 In Genital Herpes     7/24/2017
Genocea (GNCA) Reports First Quarter 2017 Financial Results And Positive Clinical Developments On Lead Candidate GEN-003 In Genital Herpes     5/4/2017
NanoBio Corporation Receives SBIR Grant For Genital Herpes Vaccine     3/6/2017
Flawed Herpes Testing Leads To Many False Positives — And Needless Suffering     1/26/2017
Genocea (GNCA) Announces Positive 6-Month Results From GEN-003 Phase 2b Clinical Trial     1/5/2017
The Center for the Biology of Chronic Disease Release: Genital Herpes - Clinical Study Recommends Gene-Eden-VIR/Novirin As A Natural Alternative To Leading Drugs For Both Severe And Mild Cases: CBCD Reports Publication Of A New Scientific Paper     10/25/2016
Rational Vaccines Release: First Ever Human Trial Of A Live Attenuated Functioning Therapeutic Herpes Vaccine     10/17/2016
Genocea (GNCA)'s Genital Herpes Candidate Successful in Mid-Stage Trial     9/29/2016
Antiviral Dietary Supplement More Effective Than Acyclovir, Valacyclovir, And Famciclovir: CBCD Reports Publication Of A New Clinical Study     9/16/2016
AiCuris Initiates Clinical Development For Topical Pritelivir, A Highly Active Inhibitor For The Treatment Of Herpes Simplex Virus     4/4/2016
NanoViricides, Inc. (NNVC.PK) Signs Agreement For Ocular Testing Of Its Drug Candidates For The Treatment Of Herpes Keratitis With The University of Pittsburgh     2/11/2016
NanoBio Corporation's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine     9/23/2015
NanoViricides, Inc. (NNVC.PK) Accelerates Its Herpes Drug Development Program     8/17/2015
NanoViricides, Inc. (NNVC.PK) Discusses The Strong Effectiveness Of Its Anti-Herpes Drug Candidates In A Lethal Animal Model Of Dermal Herpes Infection     4/27/2015
Genocea Biosciences Completes Enrollment Early In Phase 2 Dose Optimization Trial Of GEN-003 For Treatment Of Genital Herpes     1/7/2015